Found "Public health policy": 989 results
Sort by
Z - A

Advanced health biotechnologies in Thailand: State of the art, future trends and strategic preparation

Aiming at appropriate preparation for the future development of individualized and regenerative medicine (in particular, gene, stem cell and tissue engineering therapies), the Health Intervention and Technology Assessment (HITAP) program has agreed to conduct a study to provide an insight on elements necessary for national policymaking in Thailand.

Advanced health biotechnologies in Thailand: redefining policy directions. (2013)

Advanced health biotechnologies in Thailand: redefining policy directions. Román Pérez Velasco1*, Usa Chaikledkaew2,3, Chaw Yin Myint2 , Roongnapa Khampang2 , Sripen Tantivess2 and Yot Teerawattananon2* Abstract Background: Thailand faces a significant burden in terms of treating and managi

Addressing Antimicrobial Resistance in Thailand: A Policy Overview

Antimicrobial Resistance (AMR) occurs when pathogens (bacteria, viruses, fungi, and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR has been increasing in low-, middle- and high-income

Accounting for Technical, Ethical, and Political Factors in Priority Setting (2016)

Katharina Kieslich1,*, Jesse B. Bump2 , Ole Frithjof Norheim3 , Sripen Tantivess4 and Peter Littlejohns1 1 Faculty of Life Sciences & Medicine, Division of Health and Social Care Research, King’s College London, London, UK 2 Department of Global Health and Population, Harvard T. H. Chan School o

A World Without AIDS, Still Worlds Away

WASHINGTON — Is the world on the verge of ending the AIDS epidemic and creating an AIDS-free generation, even though a cure and a vaccine are still distant hopes?Yes, roared enthusiasts among the nearly 24,000 participants at the 19th International AIDS Conference here last week. Their hopes are bas

A Way Forward for the Evaluation of Health Technologies for Infectious Diseases (2014)

Pritaporn Kingkaew BPharm, MSc* * Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand Recently, many researchers undertaking health technology assessment of screening or vaccination programs for infectious diseases have opted for dynamic transmission models for th

A Tribute to Professor Sir Mike Rawlins: NICE Founding Chairman and the World Leader of Health and Social Care Guidance and Medicine Evaluation

In the death of Professor Sir Mike David Rawlins, founding chairman of the National Institute for Health and Care Excellent (NICE), who passed away at 81, the world of health and social care guidance and medicine evaluation community has lost one of its greatest leaders. Over his

A Tribute to Dr. David Banta: the Pioneer of HTA

Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B

A Terrible Beauty: A Short History of NICE The National Institute of Health and Care Excellence

“A Terrible Beauty is a relatively short account of the origins and formation of NICE, originally the National Institute for Clinical Excellence, and of its first sixteen years of operations. Together with some assessment of its impact to date.” – Nicholas Timmins –
10 / Page